Exousia Bio, Inc. Increase (Decrease) in Accrued Interest Receivable, Net
Exousia Bio, Inc. (LMMY) reported Increase (Decrease) in Accrued Interest Receivable, Net of $0 for the 3-month period ending 2025-08-31, per its 10-Q filed 2025-11-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2025-11-17
- Exousia Bio, Inc. increase (decrease) in accrued interest receivable, net for the quarter ending 2025-08-31 was $0.00.
- Exousia Bio, Inc. increase (decrease) in accrued interest receivable, net for the quarter ending 2024-08-31 was -$1.42K.
- Exousia Bio, Inc. increase (decrease) in accrued interest receivable, net for fiscal 2025 was -$436.00, a 200.00% decline from fiscal 2024.
- Exousia Bio, Inc. increase (decrease) in accrued interest receivable, net for fiscal 2024 was $436.00.
- Exousia Bio, Inc. increase (decrease) in accrued interest receivable, net for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month |
|---|---|---|
| 2025-08-31 | $0.00 10-Q · filed 2025-11-17 | |
| 2025-05-31 | -$436.00 10-K · filed 2025-10-17 | |
| 2024-08-31 | -$1.42K 10-Q · filed 2025-11-17 | |
| 2024-05-31 | $436.00 10-K · filed 2025-10-17 | |
| 2023-05-31 | $0.00 10-K · filed 2024-08-30 |